Association of HMGA2 Polymorphisms with Glioma Susceptibility in Chinese Children

References

• Malzkorn B, Reifenberger G. Practical implications of integrated glioma classification according to the World Health Organization classification of tumors of the central nervous system 2016. Curr Opin Oncol. 2016;28(6):494–501. doi:10.1097/CCO.0000000000000327
   Web of Science ®Google Scholar
• Hanz SZ, Adeuyan O, Lieberman G, Hennika T. Clinical trials using molecular stratification of pediatric brain tumors. Transl Pediatr. 2020;9(2):144–156. doi:10.21037/tp.2020.03.04
   Web of Science ®Google Scholar
• Stiller CA, Bayne AM, Chakrabarty A, Kenny T, Chumas P. Incidence of childhood CNS tumours in Britain and variation in rates by definition of malignant behaviour: population-based study. BMC Cancer. 2019;19(1):139. doi:10.1186/s12885-019-5344-7
   Web of Science ®Google Scholar
• Patel RR, Ramkissoon SH, Ross J, Weintraub L. Tumor mutational burden and driver mutations: characterizing the genomic landscape of pediatric brain tumors. Pediatr Blood Cancer. 2020;67(7):e28338. doi:10.1002/pbc.28338
   Web of Science ®Google Scholar
• Cacciotti C, Fleming A, Ramaswamy V. Advances in the molecular classification of pediatric brain tumors: a guide to the galaxy. J Pathol. 2020;251(3):249–261. doi:10.1002/path.5457
   Web of Science ®Google Scholar
• Viana-Pereira M, Moreno DA, Linhares P, et al. Replication of GWAS identifies RTEL1, CDKN2A/B, and PHLDB1 SNPs as risk factors in Portuguese gliomas patients. Mol Biol Rep. 2020;47(2):877–886. doi:10.1007/s11033-019-05178-8
   Web of Science ®Google Scholar
• Walsh KM, Rice T, Decker PA, et al. Genetic variants in telomerase-related genes are associated with an older age at diagnosis in glioma patients: evidence for distinct pathways of gliomagenesis. Neuro Oncol. 2013;15(8):1041–1047. doi:10.1093/neuonc/not051
   Web of Science ®Google Scholar
• Collins KL, Pollack IF. Pediatric low-grade gliomas. Cancers. 2020;12(5):1152. doi:10.3390/cancers12051152
   Web of Science ®Google Scholar
• Guerreiro Stucklin AS, Ryall S, Fukuoka K, et al. Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas. Nat Commun. 2019;10(1):4343. doi:10.1038/s41467-019-12187-5
   PubMed Web of Science ®Google Scholar
• Huang YM, Cheng CH, Pan SL, Yang PM, Lin DY, Lee KH. Gene expression signature-based approach identifies antifungal drug ciclopirox as a novel inhibitor of HMGA2 in colorectal cancer. Biomolecules. 2019;9(11):688. doi:10.3390/biom9110688
   Web of Science ®Google Scholar
• Chen RX, Chen X, Xia LP, et al. N(6)-methyladenosine modification of circNSUN2 facilitates cytoplasmic export and stabilizes HMGA2 to promote colorectal liver metastasis. Nat Commun. 2019;10(1):4695. doi:10.1038/s41467-019-12651-2
   PubMed Web of Science ®Google Scholar
• Zeng Z, Zhao G, Rao C, et al. Knockdown of lncRNA ZFAS1-suppressed non-small cell lung cancer progression via targeting the miR-150-5p/HMGA2 signaling. J Cell Biochem. 2019. doi:10.1002/jcb.2954
   Web of Science ®Google Scholar
• Han S, Han B, Li Z, Sun D. Downregulation of long noncoding RNA CRNDE suppresses drug resistance of liver cancer cells by increasing microRNA-33a expression and decreasing HMGA2 expression. Cell Cycle. 2019;18(19):2524–2537. doi:10.1080/15384101.2019.1652035
   PubMed Web of Science ®Google Scholar
• Titov SE, Ivanov MK, Demenkov PS, et al. Combined quantitation of HMGA2 mRNA, microRNAs, and mitochondrial-DNA content enables the identification and typing of thyroid tumors in fine-needle aspiration smears. BMC Cancer. 2019;19(1):1010. doi:10.1186/s12885-019-6154-7
   Web of Science ®Google Scholar
• Guo Z, He C, Yang F, Qin L, Lu X, Wu J. Long non-coding RNA-NEAT1, a sponge for miR-98-5p, promotes expression of oncogene HMGA2 in prostate cancer. Biosci Rep. 2019;39(9):BSR20190635. doi:10.1042/BSR20190635
   Web of Science ®Google Scholar
• Zhang S, Mo Q, Wang X. Oncological role of HMGA2 (Review). Int J Oncol. 2019;55(4):775–788. doi:10.3892/ijo.2019.4856
   PubMed Web of Science ®Google Scholar
• Li Q, Wu Q, Li Z, et al. LncRNA LINC00319 is associated with tumorigenesis and poor prognosis in glioma. Eur J Pharmacol. 2019;861:172556. doi:10.1016/j.ejphar.2019.172556
   PubMed Web of Science ®Google Scholar
• Kong J, Chen X, Wang J, et al. Genetic polymorphisms in the vitamin D pathway and non-small cell lung cancer survival. Pathol Oncol Res. 2020;26(3):1709–1715. doi:10.1007/s12253-019-00702-4
   PubMed Web of Science ®Google Scholar
• Wang Z, Dai J, Hu N, et al. Identification of new susceptibility loci for gastric non-cardia adenocarcinoma: pooled results from two Chinese genome-wide association studies. GUT. 2017;66(4):581–587. doi:10.1136/gutjnl-2015-310612
   Web of Science ®Google Scholar
• Yang Z, Deng Y, Zhang K, et al. LIN28B gene polymorphisms modify hepatoblastoma susceptibility in Chinese children. J Cancer. 2020;11(12):3512–3518. doi:10.7150/jca.42798
   Web of Science ®Google Scholar
• Pan J, Zhu J, Wang M, et al. Association of MYC gene polymorphisms with neuroblastoma risk in Chinese children: a four-center case-control study. J Gene Med. 2020;22(8):e3190. doi:10.1002/jgm.3190
   PubMed Web of Science ®Google Scholar
• Lu T, Li L, Zhu J, et al. AURKA rs8173 G>C polymorphism decreases wilms tumor risk in Chinese children. J Oncol. 2019;2019:9074908. doi:10.1155/2019/9074908
   Web of Science ®Google Scholar
• De Martino M, Fusco A, Esposito F. HMGA and cancer: a review on patent literatures. Recent Pat Anticancer Drug Discov. 2019;14(3):258–267. doi:10.2174/1574892814666190919152001
   PubMed Web of Science ®Google Scholar
• Gong J, Wang Y, Jiang B, Xu B, Hu C. Impact of high-mobility-group A2 overexpression on epithelial-mesenchymal transition in pancreatic cancer. Cancer Manag Res. 2019;11:4075–4084. doi:10.2147/CMAR.S199289
   PubMed Web of Science ®Google Scholar
• Mansoori B, Duijf PHG, Mohammadi A, et al. Overexpression of HMGA2 in breast cancer promotes cell proliferation, migration, invasion and stemness. Expert Opin Ther Targets. 2020:1–11. doi:10.1080/14728222.2020.1736559
   PubMed Web of Science ®Google Scholar
• Xiao G, Wang X, Yu Y. CXCR4/Let-7a axis regulates metastasis and chemoresistance of pancreatic cancer cells through targeting HMGA2. Cell Physiol Biochem. 2017;43(2):840–851. doi:10.1159/000481610
   PubMedGoogle Scholar
• Pan Z, Lin J, Wu D, et al. Hsa_circ_0006948 enhances cancer progression and epithelial-mesenchymal transition through the miR-490-3p/HMGA2 axis in esophageal squamous cell carcinoma. Aging. 2019;11(24):11937–11954. doi:10.18632/aging.102519
   PubMedGoogle Scholar
• Cai X, Nie J, Chen L, Yu F. Circ_0000267 promotes gastric cancer progression via sponging MiR-503-5p and regulating HMGA2 expression. Mol Genet Genomic Med. 2020;8(2):e1093. doi:10.1002/mgg3.1093
   PubMed Web of Science ®Google Scholar
• Wang Z, Wang P, Cao L, et al. Long intergenic non-coding RNA 01121 promotes breast cancer cell proliferation, migration, and invasion via the miR-150-5p/HMGA2 axis. Cancer Manag Res. 2019;11:10859–10870. doi:10.2147/CMAR.S230367
   PubMed Web of Science ®Google Scholar
• Jiao D, Liu Y, Tian Z. microRNA-493 inhibits tongue squamous cell carcinoma oncogenicity via directly targeting HMGA2. Onco Targets Ther. 2019;12:6947–6959. doi:10.2147/OTT.S210567
   PubMed Web of Science ®Google Scholar
• Ma S, Fu T, Zhao S, Gao M. MicroRNA-34a-5p suppresses tumorigenesis and progression of glioma and potentiates Temozolomide-induced cytotoxicity for glioma cells by targeting HMGA2. Eur J Pharmacol. 2019;852:42–50. doi:10.1016/j.ejphar.2019.03.005
   PubMed Web of Science ®Google Scholar
• Kaur H, Ali SZ, Huey L, et al. The transcriptional modulator HMGA2 promotes stemness and tumorigenicity in glioblastoma. Cancer Lett. 2016;377(1):55–64. doi:10.1016/j.canlet.2016.04.020
   PubMed Web of Science ®Google Scholar
• Liu X, Yidayitula Y, Zhao H, Luo Y, Ma X, Xu M. LncRNA LINC00152 promoted glioblastoma progression through targeting the miR-107 expression. Environ Sci Pollut Res Int. 2018;25(18):17674–17681. doi:10.1007/s11356-018-1784-x
   PubMed Web of Science ®Google Scholar
• Liu B, Pang B, Hou X, et al. Expression of high-mobility group AT-hook protein 2 and its prognostic significance in malignant gliomas. Hum Pathol. 2014;45(8):1752–1758. doi:10.1016/j.humpath.2014.02.028
   Web of Science ®Google Scholar
• Zhang S, Zhang H, Yu L. HMGA2 promotes glioma invasion and poor prognosis via a long-range chromatin interaction. Cancer Med. 2018;7(7):3226–3239. doi:10.1002/cam4.1534
   Web of Science ®Google Scholar
• Jia WQ, Zhu JW, Yang CY, et al. Verbascoside inhibits progression of glioblastoma cells by promoting Let-7g-5p and down-regulating HMGA2 via Wnt/beta-catenin signalling blockade. J Cell Mol Med. 2020;24(5):2901–2916. doi:10.1111/jcmm.14884
   Web of Science ®Google Scholar
• Lulli V, Buccarelli M, Ilari R, et al. Mir-370-3p impairs glioblastoma stem-like cell malignancy regulating a complex interplay between HMGA2/HIF1A and the oncogenic long non-coding RNA (lncRNA) NEAT1. Int J Mol Sci. 2020;21(10):3610. doi:10.3390/ijms21103610
   Web of Science ®Google Scholar
• Bouatia-Naji N, Marchand M, Cavalcanti-Proenca C, et al. Smallness for gestational age interacts with high mobility group A2 gene genetic variation to modulate height. Eur J Endocrinol. 2009;160(4):557–560. doi:10.1530/EJE-08-0794
   Web of Science ®Google Scholar
• Takeshita H, Fujihara J, Soejima M, et al. Confirmation that SNPs in the high mobility group-A2 gene (HMGA2) are associated with adult height in the Japanese population; wide-ranging population survey of height-related SNPs in HMGA2. Electrophoresis. 2011;32(14):1844–1851. doi:10.1002/elps.201100128
   Web of Science ®Google Scholar
• Cheng J, Zhuo Z, Yang L, et al. HMGA2 gene polymorphisms and Wilms tumor susceptibility in Chinese children: a four-center case-control study. Biotechnol Appl Biochem. 2020;67(6):939–945. doi:10.1002/bab.1857
   Web of Science ®Google Scholar
• Liu J, Hua RX, Cheng Y, et al. HMGA2 gene rs8756 A>C polymorphism reduces neuroblastoma risk in Chinese Children: a four-center case-control study. Onco Targets Ther. 2020;13:465–472. doi:10.2147/OTT.S229975
   PubMed Web of Science ®Google Scholar
• Li L, Zhuo Z, Yang Z, et al. HMGA2 polymorphisms and hepatoblastoma susceptibility: a five-center case-control study. Pharmgenomics Pers Med. 2020;13:51–57. doi:10.2147/PGPM.S241100
   PubMed Web of Science ®Google Scholar